首页> 外文期刊>Addiction biology >Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the rat
【24h】

Inhibition of glycine transporter-1 reduces cue-induced nicotine-seeking, but does not promote extinction of conditioned nicotine cue responding in the rat

机译:抑制甘氨酸转运蛋白-1减少了线索诱导的尼古丁寻找,但并未促进条件性尼古丁线索响应的灭绝

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmacological stimulation of N-methyl-D-aspartate receptors (NMDAr) could enhance the outcome of cue-exposure therapy for smoking cessation. NMDAr stimulation can be achieved by increasing pharmacologically the synaptic levels of glycine, a necessary co-agonist. Here, we evaluate the effects of SSR504734, a selective inhibitor of glycine type I transporter (GlyT1) in an extinction-reinstatement procedure inducing robust and lasting nicotine-seeking behavior in rats. Male Wistar rats were trained to associate discriminative stimuli (SDs) with the availability of nicotine (0.03 mg/kg/65 μL/2 second/infusion) or sucrose (45-mg pellet) versus non-reward in two-lever operant cages. Reinforced response was followed by cue signaling 20-second time-out (CSs). Once the training criterion was met, rats underwent extinction of lever presses, in the absence of reinforcers, SDs and CSs. Re-exposure to nicotine or sucrose SD+/CS +, but not non-reward SD-/CS-, revived responding at the previously reinforced lever. Acute pre-treatment with SSR504734 (10 mg/kg i.p.) reduced nicotine-seeking but not sucrose-seeking behavior without influencing rats' locomotor activity. Sub-chronic treatment (10 mg/kg i.p. for 5 days) during daily exposure to SD +/CS+ reduced nicotine-seeking; however, this effect was transient, with return to SD+/CS+ responding at 72 hours. Full recovery to SD+/CS+ responding was observed after 1 month suggesting that SSR504734 sub-acute treatment did not engage the long-term plasticity mechanisms probably involved in nicotine-seeking. In conclusion, GlyT1-inhibitors might offer a therapeutic opportunity for acute cue-controlled nicotine-seeking, but the lack of persistent effects of the sub-chronic treatment associated with nicotine cues exposure suggests that short-term administration of GlyT1-inhibitor SSR504734 is not sufficient to promote extinction of nicotine-cue conditioned responding.
机译:N-甲基-D-天冬氨酸受体(NMDAr)的药理刺激可以增强戒烟提示暴露疗法的效果。 NMDAr刺激可通过药理上增加必要的辅助激动剂甘氨酸的突触水平来实现。在这里,我们评估了SSR504734(一种I型甘氨酸转运蛋白(GlyT1)的选择性抑制剂)在灭绝恢复过程中诱导强效和持久的尼古丁寻找行为的作用。雄性Wistar大鼠经过训练,将判别性刺激(SDs)与尼古丁(0.03 mg / kg / 65μL/ 2秒/输液)或蔗糖(45 mg沉淀)的可用性与无奖励的两种​​杠杆操作笼子联系起来。响应增强后,提示信号20秒超时(CS)。一旦达到训练标准,大鼠将在没有增强器,SD和CS的情况下进行杠杆按压的灭绝。重新暴露于尼古丁或蔗糖SD + / CS +,但不重新暴露于SD- / CS-,没有反应,这是通过先前增强的杠杆来进行的。用SSR504734(10 mg / kg i.p.)进行的急性预处理减少了寻求尼古丁的行为,但没有减少寻求蔗糖的行为,而不影响大鼠的运动能力。每天接触SD + / CS +期间的亚慢性治疗(10 mg / kg i.p.,持续5天)减少了对尼古丁的寻求;但是,这种效果是短暂的,在72小时后回复到SD + / CS +。 1个月后观察到SD + / CS +反应完全恢复,这表明SSR504734亚急性治疗并未参与可能与尼古丁寻找有关的长期可塑性机制。总之,GlyT1抑制剂可能为急性线索控制的尼古丁寻找提供治疗机会,但是与尼古丁线索暴露相关的亚慢性治疗缺乏持续性作用表明,短期施用GlyT1抑制剂SSR504734并非如此足以促进尼古丁提示条件反应的消亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号